Table 1. Characteristics of Studies.
Reference | Study Design |
Cohort and Facility Characteristics |
Outcome Measures | Main Findings |
---|---|---|---|---|
Anderson et al.11 | Prospective | 228 PD and HD | Prevalence; | Point – prevalence: 0.4–0.6% of ESRD network population lived in NH |
(1993) | cohort | patients | Survival rate; | |
Mean age= 65.5 | Discharge Disposition) | Survival rates from Date of NH admission: | ||
6 months- 56% | ||||
Multiple NHs in 4 | 12 months- 42% | |||
states: VA, WV, MD, | ||||
DC | 12 month survival (Discharged vs. not discharged): 66% vs. 36%, p<0.05 | |||
Predictors of poor survival: | ||||
age>75 (reference (ref): age< 75): HR 1.7 (1.4–2.1) | ||||
PD (ref: HD): HR 2.0 (1.6–2.6) | ||||
ADL <8 (ref: ADL>8) HR 1.7 (1.5–2.5) | ||||
Discharge home:17% | ||||
Anderson et al.6 (1997) | Prospective | 109 PD patients | Survival rate; | Survival rates from Date of NH admission: |
cohort | Mean age = 62.7 | Discharge Disposition; | 6 months - 52% | |
Dialysis-Related Outcomes | 12 months -37% | |||
A 233-bed academic | ||||
nursing home in | Predictors of poor survival: | |||
Baltimore, MD | Age >75 (ref: age<75): HR 4.75 ( 2.56–8.86); | |||
ADL (ref: 1 ADL point lower): HR 0.91 (0.87–0.96) | ||||
CAD: HR 1.65 (1.09–2.5) | ||||
Decubitus Ulcer: HR 1.84 (1.15–2.92) | ||||
Discharge home: 37%; | ||||
Hospitalization rate: 22.4 days per patient-year | ||||
Predictors of discharge home: | ||||
Rehab admission: OR 19.14 (5.16, 71) | ||||
ADL score >8 (ref: ADL score <8): OR 4.16 (1.37–12.66) | ||||
Peritonitis rate:1 episodes per 10 patient-months | ||||
Exit-site infection rate: 1 episode per 60 patient-months | ||||
Anderson et al.14 | Prospective | 109 PD patients | Survival rate; | Survival rates from Date of NH admission: |
(2006) | cohort | Mean age = 62.7 | Advance Care Planning | 6 months: 51% |
12 months: 37% | ||||
A 233-bed academic | ||||
nursing home in | 12 month survival (DNAR vs. no DNAR): 21% vs. 44%, p<0.02 | |||
Baltimore, MD | ||||
Proportion with advance directives: 99% | ||||
DNAR: 36%; DNH: 13% | ||||
Predictors of DNAR status: | ||||
Older age: OR 1.04 (1.0007, 1.09) | ||||
CAD: OR 4.24 (1.49, 12.02) | ||||
Lower ADL score: OR 1.22 (1.08, 1.38) | ||||
Carey et al.12 | Prospective | 84 PD patients | Survival rate; | Cumulative Survival Rates from Date of NH admission: |
(2001) | cohort | Mean age = 65.3 | Discharge Disposition; | 6 months – 50% |
Dialysis-Related Outcomes | 12 months – 40% | |||
10 community based | ||||
facilities in | Discharge home:37%; | |||
New Haven, CT | Hospitalization rate: 44.6 days per patient-year | |||
Peritonitis Rate: 1 episode per 9.6 patient-months | ||||
Dharmarajan et al.10 | Cross- | 323 NH residents | Prevalence | Prevalence of Stage 5 CKD: 0.9% |
(2010) | sectional | Mean age = 83.4 | ||
study | ||||
A 350 bed urban | ||||
long-term care facility | ||||
in | ||||
Bronx, NY | ||||
Hariprasad et al.19 | Retrospective | 9 PD patients | Dialysis-Related Outcomes | Peritonitis Rate: 1 episode in 131 patient-months |
(1995) | chart review | Mean age = NR | ||
A community based | ||||
facility in Hornell, NY | ||||
Kurella Tamura et al.16 | Prospective | 3702 incident dialysis | Survival rate; | Survival Rates from Date of HD initiation: |
(2009) | cohort | patients (PD and HD) | Functional Impairment | 6 months - 50% |
Mean age = 73.4 | 12 months - 25% | |||
National sample of | Maintenance of baseline functional status: | |||
NHs identified by | 6 months - 27% | |||
linkage of MDS and | 12 months -13% | |||
USRDS datasets | ||||
Predictors of maintenance of functional status: | ||||
Older age (per 10yr): OR 0.6 (0.5–0.7) | ||||
White race: OR 0.7 (0.5–0.9) | ||||
Cerebrovascular disease: OR 0.7 (0.5–0.9) | ||||
Dementia: OR 0.6 (0.4–0.9) | ||||
Hospitalization at start: OR 0.6(0.5–0.8) | ||||
Albumin <3.5g/dL: OR 0.6(0.4–0.8) | ||||
Kurella Tamura et al. 18 | Prospective | 2402 incident dialysis | Cognitive Impairment | Proportion of patients with early dialysis initiation = 18% |
(2010) | cohort | patients (PD and HD) | Dialysis-Related Outcomes | |
Mean age = 73 | Predictors of early dialysis initiation: | |||
Edema: OR 1.54 (1.24–1.92) | ||||
National sample of | Dyspnea: OR 1.95 (1.40–2.73) | |||
NHs identified by | Moderate to severe cognitive impairment: OR 0.84 (0.67, 1.04) | |||
linkage of MDS and | Decline in cognitive function: OR 1.48 ( 1.17–1.88) | |||
USRDS datasets | ||||
Meddy 17 | Prospective | 32 PD patients | Discharge Disposition; | Discharge from NH: 6% |
(1995) | cohort | Median age = 71 | Dialysis-Related Outcomes | Peritonitis rate: 1 episode per 15 patient-months |
A 220 bed for-profit | ||||
nursing home in | ||||
Brooklyn NY | ||||
Reddy et al.13 | Prospective | 271 HD patients | Survival rate; | Survival rates from Date of NH admission: |
(2007) | cohort | Mean age = 70.5 | Discharge Dispositoin | 6 months - 38% |
12 months -26% | ||||
5 NHs in Chicago, IL | Median = 4.1 mo | |||
Survival rates from Date of HD initiation: | ||||
6 months - 75% | ||||
12 months - 66% | ||||
Median = 3.4 mo | ||||
Median Survival by dialysis vintage: | ||||
New (< 3 months of dialysis): 3.4 months | ||||
Intermediate (3–12 months of dialysis): 3.5months | ||||
Established (> 12 months of dialysis): 5.1 months (vs. New, p<0.01; vs. | ||||
Intermediate, p=0.01) | ||||
Discharge from NH: 37% | ||||
New vs. Established: 28% vs. 48%, p=0.01 | ||||
Taskapan et al. 9 | Retrospective | 38 PD patients | Survival rate; | Survival rates from Date of NH admission: |
(2010) | chart review | Mean age = 77.3 | Dialysis-Related Outcomes | 6 months – 89.5% |
12 months – 60.5% | ||||
3 NHs in | ||||
Scarborough, Toronto | Survival rates from Date of PD initiation: | |||
6 months –89.5 % | ||||
12 months – 76.3% | ||||
Peritonitis Rate: 1 episode in 40.3 patient-months | ||||
Exit-site infection rate: 1 episode per 42.4 patient-months | ||||
Troidle et al.20 | Retrospective | 77 PD patients | Dialysis-Related Outcomes | Peritonitis rate: 1 episode per 19.8 patient-months |
(2008) | chart review | Mean age = 66 | ||
Characteristics of peritonitis population (vs. no peritonitis) : | ||||
Unknown number of | Proportion of African-American race: 41% vs. 23%, p < 0.05 | |||
Nursing homes close | Average length of NH stay: 106 vs. 77 days, p < 0.05 | |||
to a dialysis unit | ||||
located in New | ||||
Haven, CT | ||||
USRDS15 | Prospective | 3,748 incident dialysis | Survival rate; | Survival rates from Date of HD initiation: |
(2011) | cohort | patients (PD and HD) | Functional Impairment | 6 months - 26%; |
Mean age = 84.2 | 12 months – 14% | |||
National sample of | Predictors of Death at 6 months(among all NH residents): | |||
NHs identified by | Recent Dialysis Initiation (ref: non-CKD NH residents): HR 2.54 (2.36- | |||
linkage of MDS and | 2.73) | |||
USRDS datasets | ||||
Maintenance of baseline functional status: | ||||
6 months - 10% | ||||
12 months - 6% | ||||
Maintenance of baseline cognitive scores: | ||||
6 months – 17% | ||||
12 months – 10% | ||||
Predictor of maintenance of functional status at 6 months: | ||||
Recent Dialysis Initiation (ref: non-CKD NH residents): OR 0.69 (0.69 | ||||
0.58–0.82) | ||||
Wang et al. 8 | Retrospective | 8 PD patients | Dialysis-Related Outcomes | Peritonitis rate: |
(2002) | chart review | Mean age = 77.3 | 1 episodes per 7.5 patient-months | |
A community based | ||||
facility in Toronto |
Abbreviations: PD, peritoneal dialysis; HD, hemodialysis; NH, nursing home; ESRD, end-stage renal disease; ADL, activities of daily living; HR, hazard ratio; CAD, coronary artery disease; SD, standard deviation; DNAR, do not attempt resuscitation; DNH, do not hospitalize; OR, odds ratio; CKD, chronic kidney disease; NR, not reported; MDS, Minimum Data Set; USRDS, United States Renal Data System.